Skip navigation

Improve Access and Outcomes Across the Care Continuum

August 21-22, 2019
  • Philadelphia, PA

Driven by payer reform, technological and scientific advances and consumer demands, the healthcare industry is undergoing unprecedented transformation. The shift from volume- to value-based payment and care delivery has driven healthcare providers to reshape their approach and many have answered the call for personalized, convenient and coordinated patient care by forming large organizations such as IDNs and ACOs.

Understanding these complex health systems and how they interact with all of the industry’s stakeholders is crucial for manufacturers to better support and meet the needs of these growing networks.

To address the challenges and opportunities ahead, join a distinguished group of industry pioneers at CBI’s 4th Annual Partnering with IDNs BioPharma Strategy Summit, for a highly collaborative meeting on refining care coordination, increasing patient engagement and adherence, and ultimately, improving patient outcomes.

Previous Attendee Acclaim:

Always get so much out of these sessions
and they get better every time.

Senior Manager, Commercial Excellence, Sanofi

Most informative and collaborative conference I’ve been to
in years. It is one of the most thought-provoking events.
Thank you so much for all your hard work and attention
to quality of content and speakers.

Founding Partner, Blue Fin Group

Well organized and good speaker selection.

Assistant Director, Specialty Pharmacy Services, University of Illinois

The knowledge base and experience of the attendees exceeded my expectations. The conference truly was a
working session more than a speaker’s conference.

Principal/Chief Operating Officer, Curant Health

The conference helped me understand the needs for all stakeholders. Manufacturers and IDNS can help each other and improve outcomes for patients as specialty drugs continue to grow as a percentage of pharmacy budgets.

Senior Director, Acentrus

Some of the biggest changes in the healthcare space are occurring around IDNs, ACOs and payers. This is a dynamic part of the market and this conference provides relevant
content and perspectives surrounding it.

Head of Global MDM, Lexis Nexis

4th Annual Partnering with IDNs BioPharma Strategy Summit

Improve Access and Outcomes Across the Care Continuum

Driven by payer reform, technological and scientific advances and consumer demands, the healthcare industry is undergoing unprecedented transformation. The shift from volume- to value-based payment and care delivery has driven healthcare providers to reshape their approach and many have answered the call for personalized, convenient and coordinated patient care by forming large organizations such as IDNs and ACOs.

Understanding these complex health systems and how they interact with all of the industry’s stakeholders is crucial for manufacturers to better support and meet the needs of these growing networks.

To address the challenges and opportunities ahead, join a distinguished group of industry pioneers at CBI’s 4th Annual Partnering with IDNs BioPharma Strategy Summit, for a highly collaborative meeting on refining care coordination, increasing patient engagement and adherence, and ultimately, improving patient outcomes.

Previous Attendee Acclaim:

Always get so much out of these sessions
and they get better every time.

Senior Manager, Commercial Excellence, Sanofi

Most informative and collaborative conference I’ve been to
in years. It is one of the most thought-provoking events.
Thank you so much for all your hard work and attention
to quality of content and speakers.

Founding Partner, Blue Fin Group

Well organized and good speaker selection.

Assistant Director, Specialty Pharmacy Services, University of Illinois

The knowledge base and experience of the attendees exceeded my expectations. The conference truly was a
working session more than a speaker’s conference.

Principal/Chief Operating Officer, Curant Health

The conference helped me understand the needs for all stakeholders. Manufacturers and IDNS can help each other and improve outcomes for patients as specialty drugs continue to grow as a percentage of pharmacy budgets.

Senior Director, Acentrus

Some of the biggest changes in the healthcare space are occurring around IDNs, ACOs and payers. This is a dynamic part of the market and this conference provides relevant
content and perspectives surrounding it.

Head of Global MDM, Lexis Nexis